Piper Sandler cuts ANI Pharmaceuticals target price to $91 from $98
ANIP•Piper Sandler cut its target price for ANI Pharmaceuticals to $91 from $98.
Related News
Centrus Energy Corp.: JPMorgan cuts target price to $100 from $120
LEU•
JP Morgan cuts MACOM Technology Solutions Holdings target price to $280 from $345
MTSI•
Prudential cuts deemed stake in Frontken to 5.104%
PUK•
SiTime Corporation: Seaport Research Partners raises to buy from neutral
SITM•
Canadian Natural Resources Ltd: RBC raises target price to C$88 from C$86
CNQ•